AtriCure Inc

ATRC

Company Profile

  • Business description

    AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

  • Contact

    7555 Innovation Way
    MasonOH45040
    USA

    T: +1 513 755-4100

    E: [email protected]

    https://www.atricure.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2025

    Employees

    1,300

Stocks News & Analysis

stocks

Small caps are catching fire

For good reason.
stocks

Moated ASX player’s future growth prospects look solid

We expect the strong earnings momentum at this company to continue, with shares looking fairly valued.
stocks

Ask the analyst: Can this genius product create the next ASX software king?

SiteMinder’s newly released product for hotel owners and travel agents could widen its moat and see revenue accelerate further.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,030.9039.90-0.44%
CAC 407,879.8292.841.19%
DAX 4023,646.12286.941.23%
Dow JONES (US)46,018.32260.420.57%
FTSE 1009,225.7917.420.19%
HKSE26,544.85363.54-1.35%
NASDAQ22,261.3372.63-0.33%
Nikkei 22545,303.43513.051.15%
NZX 50 Index13,120.03108.35-0.82%
S&P 5006,600.356.41-0.10%
S&P/ASX 2008,745.2047.70-0.54%
SSE Composite Index3,831.6644.68-1.15%

Market Movers